Shiven Ramji
Known title: Chief Executive OfficerCIK: 0002133891
Associated companies
Transaction History
| CLBT | ▲ Buy | Grant | 38,505 | $0 | 9/24/2026 | View on chart |
| CLBT | ▲ Buy | Grant | 423,550 | $0 | 5/12/2026 | View on chart |
| CLBT | ▲ Buy | Grant | 38,505 | $0 | 9/24/2026 | View on chart |
| CLBT | ▲ Buy | Grant | 423,550 | $0 | 5/12/2026 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
CLBT Featured in Retail Watchlist Amid Cooling Inflation
Cellebrite was included in a Yahoo Finance article listing three US growth tech stocks that retail investors are watching due to cooling inflation. The stock is currently trading near a key support level, with an average analyst target of $15.36. This mention highlights ongoing retail interest in the company's growth potential.
CLBT Featured in Retail Watchlist Amid Cooling Inflation. Cellebrite was included in a Yahoo Finance article listing three US growth tech stocks that retail investors are watching due to cooling inflation. The stock is currently trading near a key support level, with an average analyst target of $15.36. This mention highlights ongoing retail interest in the company's growth potential.